
Sun Pharma has recalled several eye drop products in India after contamination concerns were identified during manufacturing. The company has asked distributors to stop supplying the affected medicines and return stock. Products…
Sun Pharma has recalled several eye drop products in India after contamination concerns were identified during manufacturing. The company has asked distributors to stop supplying the affected medicines and return stock. Products include Depopred, Brinolar, Brinzotim, Lotepred, Nepalact, and Toba-F drops, used for glaucoma, infections, allergies, and post-surgery care.
Health experts advise patients not to panic but to contact their ophthalmologist immediately. Do not stop treatment without medical advice, especially glaucoma medicines, as abrupt stoppage can raise eye pressure and risk vision loss. Sun Pharma says patient safety is the priority and is working to restore safe supplies.
Recalls create alarm, but they also show quality checks working before harm occurs. Social media may urge patients to abandon prescriptions altogether, that is dangerous. The real test is whether doctors quickly offer alternatives and patients stay calm enough to seek professional advice instead of self-detoxifying. Will those using the recalled drops actually call their ophthalmologist before acting on rumour?
Source: timesnownews.com
This story was synthesised by AI from the source linked above.